Naptumomab Estafenatox (TPBG) - Research Grid Biosimilar
Gecertificeerd

Naptumomab Estafenatox (TPBG) - Research Grid Biosimilar

Catalog #: 10-087
Maat: 0.1 mg

Kwaliteit

ISO Gecertificeerd

Levering

24-48 uur

Prijs -1%
Login voor prijs
BTW niet inbegrepen
Gratis verzending vanaf €100
Technische Documentatie

Technische Specificaties

Background

Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.

Immunogen

Mus musculus / TPBG [Homo sapiens]

Clonality

• Recombinant Monoclonal

Conjugation

Unconjugated

Type

Primary Antibodies, Biosimilars

Source

CHO cells

Field of Research

Cancer

Purification

>95%

Concentration

Batch dependent

Buffer

PBS buffer pH7.5

Modification

None

Shipping Conditions

Blue Ice

Storage Conditions

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.

Fragment

Fab-G1-kappa

Specificity

Please note: 10-087 is the pure recombinant antibody Naptumomab without Estafenatox fragment. The original antibody drug is the fusion protein «Naptumomab + Estafenatox», however, the research grade biosimilar we can supply is the recombinant antibody without any conjugation or any fragment.

NCBI Organism

Homo sapiens

Other Product Names

ABR-217620, ANYARA, TTS CD3, TPBG, TPBG

Beschrijving

Naptumomab Estafenatox (TPBG) - Research Grid Biosimilar Beschikbaar in 0.1 mg. Bestel eenvoudig online met snelle levering.

Specificaties

ProductnaamNaptumomab Estafenatox (TPBG) - Research Grid Biosimilar
Categorie
Beschikbare grootte0.1 mg
Catalogusnummer10-087